enrofloxacin has been researched along with Bone Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rebhun, RB; Seo, KW; Watson, KD; Withers, SS; York, D | 1 |
1 other study(ies) available for enrofloxacin and Bone Cancer
| Article | Year |
|---|---|
Enrofloxacin enhances the effects of chemotherapy in canine osteosarcoma cells with mutant and wild-type p53.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Carboplatin; Cell Line, Tumor; Chemotherapy, Adjuvant; Dog Diseases; Dogs; Doxorubicin; Enrofloxacin; Fluoroquinolones; Osteosarcoma; Tumor Suppressor Protein p53 | 2017 |